Craft Cannabis – By Ray Mwareya

The approval of license applications for craft cannabis growers in Canada is so slow that, micro-cultivators say, for 150 license requests submitted by March 2018, only two were granted by this point in 2019, and none of the licenses are for growers in Alberta (arguably the country ́s richest province), and the only province where rules forbid growers from selling directly to retailers.

Strain Report – Gelato Kush, By Kush Cannabis Seeds

Kush Cannabis Seeds have been breeding for over 15 years. Their genetics have been collected from the purest strains that date back generations in the Hindu Kush and decades in North America. They have searched long and hard for genetics that are stable and offer something far from the norm, while taking the utmost care to only release what we know is the best, which is why we are releasing them to you; we have been meticulous in our production to ensure you have the best quantity and quality available.

Medical use of cannabis in Switzerland: analysis of approved exceptional licences

In recent years, the Swiss Federal Office of Public Health (FOPH) granted exceptional licenses for the medical use of cannabinoids, typically for 6 months with possible extensions. A systematic review of cannabinoids for medical use commissioned by the FOPH supports the use of cannabinoids for the treatment of chronic pain and spasticity. Exceptional licences for medical use of cannabinoids have increased substantially in Switzerland, with the programme including patients with a wide range of conditions.

Medical use of cannabis in Switzerland: analysis of approved exceptional licences

In recent years, the Swiss Federal Office of Public Health (FOPH) granted exceptional licenses for the medical use of cannabinoids, typically for 6 months with possible extensions. A systematic review of cannabinoids for medical use commissioned by the FOPH supports the use of cannabinoids for the treatment of chronic pain and spasticity. However, little is known about the patients treated with cannabinoids. We aimed to study medical uses of cannabinoids as part of the FOPH’s programme of exceptional licenses.